OwlTail

Cover image of Alice Shaw

Alice Shaw

7 Podcast Episodes

Latest 1 May 2021 | Updated Daily

Weekly hand curated podcast episodes for learning

Episode artwork

S1, Ep1 Well Undone: Alice Shaw

Well Undone with Lydia Allaby

My guest this week is Alice Shaw, a mid-twenties City lawyer who talks honestly and powerfully about her experience of juggling life alongside the world of eating disorders. She shares how she first fell down the slippery slope of restrictive eating, her experience with therapy, the impact that her eating disorder has had on her relationships, and so much more.If you are personally struggling with any of the issues discussed in this episode, there are resources out there to help. A great first port of call, if you are in the UK, is the charity BEAT: https://www.beateatingdisorders.org.uk/support-services/helplines If you are keen to explore further the ideas around intuitive eating and the Health At Every Size movement, I would recommend taking a look at the work by Laura Thomas PhD (@laurathomasphd), author and founder of the London Centre for Intuitive Eating. Well Undone is hosted and produced by Lydia Allaby.

43mins

4 Jan 2021

Episode artwork

LCU2 2016 | Interview with Alice Shaw, MD, PhD

Lung Cancer Update

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Alice Shaw, MD, PhD conducted by Neil Love, MD. Produced by Research To Practice.

33mins

2 Sep 2016

Similar People

Episode artwork

NEJM Interview: Dr. Alice Shaw on a new model for accelerating the development of promising oncology drugs.

New England Journal of Medicine Interviews

Dr. Alice Shaw is a thoracic oncologist at the Massachusetts General Hospital Cancer Center. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. T.M. Prowell, M.R. Theoret, and R. Pazdur. Seamless Oncology-Drug Development. N Engl J Med 2016;374:2001-3.

10mins

25 May 2016

Episode artwork

LCU1 2013 | Interview with Alice Shaw, MD, PhD

Lung Cancer Update

Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Alice Shaw, MD, PhD conducted by Neil Love, MD. Produced by Research To Practice.

36mins

11 Jul 2013

Most Popular

Episode artwork

Treatment of ALK+ lung cancer with crizotinib, Profile 1007 Dr Alice Shaw – Massachusetts General Hospital, Boston, USA

ESMO Congress 2012

Dr Alice Shaw talks to ecancer at the 2012 ESMO meeting in Vienna about a randomised phase III study comparing targeted therapy crizotinib with standard chemotherapy in cases of ALK+ lung cancer. ALK+ lung cancer is defined by a genetic abnormality and is present in about 5% of the total lung cancer population. The trial looked to increase progression free survival; results confirmed with a 7.7 month average increase with crizotinib compared to 3 months with standard chemotherapy. The total response rate with crizotinib was 65.3 percent. Side effects that occurred were visual disturbance, nausea vomiting diarrhea, liver irritation, but all were at manageable levels.

3mins

17 Oct 2012

Episode artwork

Molecular Markers in Lung Cancer Pt 2: Dr. Alice Shaw on Mutation Patterns by Patient Features (audio)

GRACEcast Lung Cancer Audio

Dr. Alice Shaw from Massachusetts General Hospital reviews the frequency of molecular markers in lung cancer by patient sex, smoking status, race, and histology.

10mins

14 Apr 2012

Episode artwork

LCU0110 | Interview with Alice Shaw, MD, PhD

Lung Cancer Update

ResearchToPractice.com/LCU110 – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Care. Interview with Alice Shaw, MD, PhD conducted by Neil Love, MD. Produced by Research To Practice.

37mins

8 Mar 2010